Avalo Therapeutics Inc. buy Wedbush
Start price
20.03.25
/
50%
€0.041
Target price
20.03.26
€16.51
Performance (%)
-
End price
21.03.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Avalo Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -3,64 % | -8,78 % | -0,69 % |
| iShares Nasdaq 100 | -2,99 % | -1,71 % | 11,95 % |
| iShares Nikkei 225® | -3,00 % | -9,10 % | 23,39 % |
| iShares S&P 500 | -2,39 % | -2,78 % | 7,62 % |
Comments by Wedbush for this prediction
In the thread Avalo Therapeutics Inc. diskutieren
Avalo Therapeutics, Inc. (NASDAQ: AVTX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
In the thread Trading Avalo Therapeutics Inc.
Die von Wedbush gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Wedbush for Avalo Therapeutics Inc.
Avalo Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.041
21.02.25
21.02.25
€17.18
21.02.26
21.02.26
-
22.02.26
22.02.26
